Messore, A.; Malune, P.; Patacchini, E.; Madia, V.N.; Ialongo, D.; Arpacioglu, M.; Albano, A.; Ruggieri, G.; Saccoliti, F.; Scipione, L.;
et al. New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors. Pharmaceuticals 2024, 17, 650.
https://doi.org/10.3390/ph17050650
AMA Style
Messore A, Malune P, Patacchini E, Madia VN, Ialongo D, Arpacioglu M, Albano A, Ruggieri G, Saccoliti F, Scipione L,
et al. New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors. Pharmaceuticals. 2024; 17(5):650.
https://doi.org/10.3390/ph17050650
Chicago/Turabian Style
Messore, Antonella, Paolo Malune, Elisa Patacchini, Valentina Noemi Madia, Davide Ialongo, Merve Arpacioglu, Aurora Albano, Giuseppe Ruggieri, Francesco Saccoliti, Luigi Scipione,
and et al. 2024. "New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors" Pharmaceuticals 17, no. 5: 650.
https://doi.org/10.3390/ph17050650
APA Style
Messore, A., Malune, P., Patacchini, E., Madia, V. N., Ialongo, D., Arpacioglu, M., Albano, A., Ruggieri, G., Saccoliti, F., Scipione, L., Tramontano, E., Canton, S., Corona, A., Scognamiglio, S., Paulis, A., Suleiman, M., Al-Maqtari, H. M., Abid, F. M. A., Kawsar, S. M. A.,
... Costi, R.
(2024). New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors. Pharmaceuticals, 17(5), 650.
https://doi.org/10.3390/ph17050650
